Dance Marches On For Biosimilars In Amgen V. Sandoz
Two sections of the Biologics Price Competition and Innovation Act of 2009 are the subject of writs of certiorari that have just been granted by the U.S. Supreme Court to the...To view the full article, register now.
Already a subscriber? Click here to view full article